Pharming Group N.V. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-12-16: Form 6-K; Period of report 2024-12-15; Description 6-K; Document pharmingannouncespubliccas.htm.
- 2024-12-11: Form 6-K; Period of report 2024-12-11; Description 6-K; Document pharmingannouncespositivet.htm.
- 2024-10-24: Form 6-K; Period of report 2024-10-24; Description 6-K; Document a2024q3pressrelease.htm.
- 2024-10-10: Form 6-K; Period of report 2024-10-10; Description 6-K; Document pharminggroupannouncesstrt.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-12-16 | 6-K | 2024-12-15 | 6-K | pharmingannouncespubliccas.htm |
| 2024-12-11 | 6-K | 2024-12-11 | 6-K | pharmingannouncespositivet.htm |
| 2024-10-24 | 6-K | 2024-10-24 | 6-K | a2024q3pressrelease.htm |
| 2024-10-10 | 6-K | 2024-10-10 | 6-K | pharminggroupannouncesstrt.htm |
| 2024-09-26 | 6-K | 2024-09-26 | 6-K | pharmingannouncesmarketing.htm |
| 2024-08-01 | 6-K | 2024-08-01 | 6-K | a2024hy1pressrelease.htm |
| 2024-05-30 | 6-K | 2024-05-30 | 6-K | pharminggroupprovidesupdat.htm |
| 2024-05-21 | 6-K | 2024-05-21 | 6-K | pharminggroupreportsonresu.htm |
| 2024-05-15 | 6-K | 2024-05-15 | 6-K | pharmingearlyconvertiblebo.htm |
| 2024-05-08 | 6-K | 2024-05-08 | 6-K | a2024q1pressrelease.htm |
| 2024-04-25 | 6-K | 2024-04-25 | 6-K | pharmingconvertiblebondref.htm |
| 2024-04-24 | 6-K | 2024-04-24 | 6-K | pharmingnordawardpr.htm |
| 2024-04-08 | 6-K | 2024-04-08 | 6-K | pharmingped1completionofen.htm |
| 2024-04-04 | 6-K | 2024-04-04 | 6-K | ar2320-fandagm.htm |
| 2024-03-14 | 6-K | 2024-03-14 | 6-K | pharminggroup4q2023financi.htm |
| 2024-01-08 | 6-K | 2024-01-08 | 6-K | businessandguidanceupdate2.htm |